5F 203
CAS No. 260443-89-8
5F 203( 5F-203 | 5F203 | NSC 703786 | NSC703786 )
Catalog No. M13790 CAS No. 260443-89-8
A potent, selective antitumour agent through activation the aryl hydrocarbon receptor (AhR) pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 84 | Get Quote |
|
| 10MG | 132 | Get Quote |
|
| 25MG | 267 | Get Quote |
|
| 50MG | 410 | Get Quote |
|
| 100MG | 605 | Get Quote |
|
| 500MG | 1242 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name5F 203
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective antitumour agent through activation the aryl hydrocarbon receptor (AhR) pathway.
-
DescriptionA potent, selective antitumour agent through activation the aryl hydrocarbon receptor (AhR) pathway; causes MCF-7 sensitive cells to arrest in G(1) and S phase, and induces DNA adduct formation, in contrast to AhR-deficient AH(R100) variant MCF-7 cells, induces CYP1A1 and CYP1B1 transcription; L-lysylamide prodrug Phortress (NSC 710305) demonstrats antitumor activity in vivo.
-
In Vitro——
-
In Vivo——
-
Synonyms5F-203 | 5F203 | NSC 703786 | NSC703786
-
PathwayEndocrinology/Hormones
-
TargetAhR
-
RecptorAhR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number260443-89-8
-
Formula Weight258.314
-
Molecular FormulaC14H11FN2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (387.13 mM)
-
SMILESCC1=C(C=CC(=C1)C2=NC3=C(S2)C=CC(=C3)F)N
-
Chemical Name2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bradshaw TD, et al. Mol Cancer Ther. 2002 Feb;1(4):239-46.
2. Gilbert J, et al. Mol Pharmacol. 2017 Dec 21. pii: mol.117.109827.
3. Trapani V, et al. Br J Cancer. 2003 Feb 24;88(4):599-605.
4. Leong CO, et al. Br J Cancer. 2003 Feb 10;88(3):470-7.
molnova catalog
related products
-
PDM 11
PDM 11 is an antagonist of aryl hydrocarbon receptor (AhR).
-
YL-109
YL-109 is a novel anticancer agent which has ability to inhibit breast Y cell growth and invasiveness in vitro and in vivo.
-
TCDD
A potent AHR (aryl hydrocarbon receptor) agonist that induces degradation of AhR by the ubiquitin-proteasome pathway.
Cart
sales@molnova.com